Suppr超能文献

促进 NAD:银屑病中 Th17 细胞代谢重编程的机会。

Boosting NAD: An opportunity for metabolic reprogramming of Th17 cells in psoriatic disease.

机构信息

Department of Translational Medicine, University of Ferrara, via Luigi Borsari 46, 44121 Ferrara, Italy.

出版信息

Cell Rep Med. 2023 Sep 19;4(9):101163. doi: 10.1016/j.xcrm.2023.101163.

Abstract

Metabolic reprogramming of CD4 T cells has become an opportunity for adjunctive therapies. Here, Han et al. show that boosting NAD blunts systemic Th17 responses and increases antioxidant pathways through arginine and fumarate-mediated activation of NRF2 transcription factor.

摘要

CD4 T 细胞的代谢重编程已成为辅助治疗的机会。在这里,Han 等人表明,提高 NAD 水平可通过精氨酸和富马酸介导的 NRF2 转录因子激活来减轻全身性 Th17 反应并增加抗氧化途径。

相似文献

1
Boosting NAD: An opportunity for metabolic reprogramming of Th17 cells in psoriatic disease.
Cell Rep Med. 2023 Sep 19;4(9):101163. doi: 10.1016/j.xcrm.2023.101163.
2
Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects.
Cell Rep Med. 2023 Sep 19;4(9):101157. doi: 10.1016/j.xcrm.2023.101157. Epub 2023 Aug 15.
4
Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4 T Cells.
J Immunol. 2021 Apr 1;206(7):1540-1548. doi: 10.4049/jimmunol.1900656. Epub 2021 Mar 1.
5
Increased HIF-1α expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus.
J Formos Med Assoc. 2022 Dec;121(12):2446-2456. doi: 10.1016/j.jfma.2022.05.003. Epub 2022 May 20.
7
The Pathogenic Subpopulation of Th17 Cells in Obesity.
Curr Pharm Des. 2021;27(37):3924-3938. doi: 10.2174/1381612826666210101154913.
8
Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.
Gut. 2015 May;64(5):765-75. doi: 10.1136/gutjnl-2013-306585. Epub 2014 Jul 10.
9
Deciphering targets of Th17 cells fate: From metabolism to nuclear receptors.
Scand J Immunol. 2019 Oct;90(4):e12793. doi: 10.1111/sji.12793. Epub 2019 Jul 23.
10
The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.
J Immunol. 2014 Jan 1;192(1):178-88. doi: 10.4049/jimmunol.1301372. Epub 2013 Nov 20.

引用本文的文献

1
CRISPR-Cas9 applications in T cells and adoptive T cell therapies.
Cell Mol Biol Lett. 2024 Apr 12;29(1):52. doi: 10.1186/s11658-024-00561-1.

本文引用的文献

1
Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects.
Cell Rep Med. 2023 Sep 19;4(9):101157. doi: 10.1016/j.xcrm.2023.101157. Epub 2023 Aug 15.
2
N-arachidonylglycine is a caloric state-dependent circulating metabolite which regulates human CD4T cell responsiveness.
iScience. 2023 Apr 6;26(5):106578. doi: 10.1016/j.isci.2023.106578. eCollection 2023 May 19.
4
Metabolic adaptation of lymphocytes in immunity and disease.
Immunity. 2022 Jan 11;55(1):14-30. doi: 10.1016/j.immuni.2021.12.012.
5
Fasting-induced FOXO4 blunts human CD4 T helper cell responsiveness.
Nat Metab. 2021 Mar;3(3):318-326. doi: 10.1038/s42255-021-00356-0. Epub 2021 Mar 15.
6
NAD metabolism and its roles in cellular processes during ageing.
Nat Rev Mol Cell Biol. 2021 Feb;22(2):119-141. doi: 10.1038/s41580-020-00313-x. Epub 2020 Dec 22.
8
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.
Front Immunol. 2020 Jan 15;10:3096. doi: 10.3389/fimmu.2019.03096. eCollection 2019.
9
Increased Mitochondrial Biogenesis and Reactive Oxygen Species Production Accompany Prolonged CD4 T Cell Activation.
J Immunol. 2018 Dec 1;201(11):3294-3306. doi: 10.4049/jimmunol.1800753. Epub 2018 Oct 29.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验